Citi raised the firm’s price target on Colgate-Palmolive to $95 from $93 and keeps a Buy rating on the shares. The company reported “very strong” Q4 results and provided 2024 guidance in-line with the algorithm, the analyst tells investors in a research note. The firm believes Colgate’s “superior” growth profile will become even more evident as 2024 unfolds, with room to beat and raise throughout the year relative to a “conservative” guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CL:
- Colgate-Palmolive (NYSE:CL) Gains on Strong Q4 Print
- Options Volatility and Implied Earnings Moves Today, January 26, 2024
- Colgate-Palmolive reports Q4 base gross profit margin up 400 bps to 59.6%
- Colgate-Palmolive ‘well positioned’ to deliver compounded EPS growth in FY24
- Colgate-Palmolive sees FY24 net revenue growth 1%-4%, consensus $20.07B